RSSS•November 16, 2026 at 9:05 PM UTCSoftware & Services

Research Solutions' Q1 FY27 Shows Sharp ARR Deceleration, B2B Growth Slows to 11.5%

Read source article

What happened

Research Solutions reported Q1 FY2027 results with B2B ARR up 11.5% YoY and total ARR of $22.5 million. This implies total ARR grew only about 5.6% from the $21.3 million reported a year earlier, a sharp slowdown from the 21% YoY growth in the prior-year quarter. The deceleration appears driven by flat or declining B2C ARR, while B2B growth, though still positive, fell well below the ~20% pace previously observed. The press release highlights the B2B ARR increase and the $22.5 million milestone but omits the overall growth rate, a common tactic to mask weakness. Investors should treat the news with caution and await the full earnings release for segment-level details.

Implication

The sharp deceleration in total ARR growth from 21% to roughly 5.6% directly undermines a key pillar of the prior 'POTENTIAL BUY' thesis, which assumed sustained ~20%+ ARR growth. While B2B ARR still grew 11.5%, that is insufficient to maintain conviction, especially given the company's narrow moat and concentrated supplier risk. Investors should closely monitor next quarter's ARR to determine if this is an anomaly or a trend; any further slippage could justify a downgrade to WAIT or POTENTIAL SELL. Meanwhile, the net-cash balance sheet and positive free cash flow offer some downside protection, but the margin of safety has clearly narrowed. Until the company demonstrates re-acceleration or improved mix and margins, the risk-reward is no longer compelling for new buyers.

Thesis delta

The previous thesis leaned bullish on the back of 21% ARR growth and improving profitability, but this new data reveals a significant slowdown. The shift from 21% to roughly 5.6% total ARR growth challenges the growth durability assumption and reduces upside potential. Accordingly, the stance moves from POTENTIAL BUY to a more neutral WAIT, pending further evidence of stabilization or re-acceleration.

Confidence

Moderate